Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TLR2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TLR2 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with ALS, ALZHEIMER'S DISEASE, Aging. Connected to 284 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TLR2 |
| Full Name | Toll-Like Receptor 2 |
| Chromosome | 4q31.3 |
| Protein Type | Receptor |
| Function | TLR2 is expressed in microglia, astrocytes, and neurons throughout the brain. |
| Primary Expression | microglia, astrocytes, and neurons throughout the brain |
| Amino Acids | 784 aa |
| Exons | 3 |
| Pathways | NF-κB, PI3K |
| UniProt ID | Q9Y257 |
| NCBI Gene ID | 7103 |
| Ensembl ID | ENSG00000137462 |
| OMIM | 603028 |
| GeneCards | TLR2 |
| Human Protein Atlas | TLR2 |
| Associated Diseases | Als, Alzheimer, Brain Injury, Fibrosis, HYPOXIC-ISCHEMIC ENCEPHALOPATHY |
| Known Drugs/Compounds | C29 |
| Interactions | AKT, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND |
| KG Connections | 685 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
TLR2["TLR2
Toll-like Receptor 2"]
TRAF6["TRAF6
TNF Receptor
Associated Factor 6"]
NFKB["NF-kappaB
Nuclear Factor
Kappa B"]
IRF3["IRF3
Interferon
Regulatory Factor 3"]
STING1["STING1
Stimulator of
Interferon Genes"]
ALPHA_SYN["alpha-synuclein
Protein Aggregation"]
AUTOPHAGY["Autophagy
Cellular Clearance
Mechanism"]
C3["C3
Complement
Component"]
NEUROINFLAM["Neuroinflammation
CNS Immune
Activation"]
PARKINSON["Parkinson's Disease
Motor Neuron
Degeneration"]
ALZHEIMER["Alzheimer's Disease
Cognitive
Decline"]
ALS["ALS
Motor Neuron
Disease"]
MS["Multiple Sclerosis
Demyelinating
Disease"]
NEURODEGENERATION["Neurodegeneration
Progressive
Cell Death"]
TLR2 -->|"associates with"| TRAF6
TRAF6 -->|"activates"| NFKB
TLR2 -->|"activates"| NFKB
TLR2 -->|"inhibits"| IRF3
TLR2 -->|"modulates"| STING1
TLR2 -->|"regulates"| C3
TLR2 -->|"promotes"| ALPHA_SYN
TLR2 -->|"inhibits"| AUTOPHAGY
NFKB -->|"drives"| NEUROINFLAM
NEUROINFLAM -->|"leads to"| NEURODEGENERATION
ALPHA_SYN -->|"contributes to"| PARKINSON
TLR2 -->|"activates"| NEUROINFLAM
TLR2 -->|"associated with"| PARKINSON
TLR2 -->|"regulates"| ALZHEIMER
TLR2 -->|"activates"| ALS
TLR2 -->|"activates"| MS
NEURODEGENERATION -->|"manifests as"| PARKINSON
NEURODEGENERATION -->|"manifests as"| ALZHEIMER
NEURODEGENERATION -->|"manifests as"| ALS
NEURODEGENERATION -->|"manifests as"| MS
style TLR2 fill:#006494
style AUTOPHAGY fill:#1b5e20
style IRF3 fill:#4a1a6b
style TRAF6 fill:#4a1a6b
style STING1 fill:#4a1a6b
style C3 fill:#4a1a6b
style NFKB fill:#ef5350
style NEUROINFLAM fill:#ef5350
style ALPHA_SYN fill:#ef5350
style PARKINSON fill:#5d4400
style ALZHEIMER fill:#5d4400
style ALS fill:#5d4400
style MS fill:#5d4400
style NEURODEGENERATION fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Nlrp3 Inflammasome | activates | protein | 0.95 |
| NLRP3 | activates | gene | 0.95 |
| Pyroptosis | promotes | process | 0.92 |
| Neonatal Hypoxic-Ischemic Brain Injury | therapeutic_target | disease | 0.92 |
| GSDMD | upregulates | gene | 0.90 |
| inflammatory cytokine production | activates | mechanism | 0.90 |
| tau aggregates | recognizes | mechanism | 0.90 |
| STING1 | regulates | protein | 0.90 |
| Brain Injury | causes | phenotype | 0.88 |
| Neuronal Apoptosis | promotes | process | 0.88 |
| brain injury | drives | phenotype | 0.88 |
| rosacea | associated_with | disease | 0.85 |
| neuronal apoptosis | promotes | process | 0.85 |
| IBA1 | upregulates | gene | 0.82 |
| NF-κB | activates | protein | 0.80 |
| IRF3 | inhibits | protein | 0.80 |
| TRAF6 | associated_with | protein | 0.80 |
| cytokines | produces | process | 0.80 |
| HYPOXIC-ISCHEMIC ENCEPHALOPATHY | associated_with | disease | 0.80 |
| Parkinson | activates | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| MTOR | associated_with | protein | 0.75 |
| IMMUNE RESPONSE | mediates | pathway | 0.75 |
| Parkinson's disease | associated_with | disease | 0.70 |
| Toll-Like Receptor | activates | pathway | 0.70 |
| autophagy | inhibits | process | 0.70 |
| α-synuclein | activates | protein | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| Nf-Κb | inhibits | pathway | 0.70 |
| PARKINSON'S DISEASE | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| NF-ΚB | inhibits | gene | 0.70 |
| NEURON | activates | gene | 0.70 |
| Toll-Like Receptor | regulates | pathway | 0.70 |
| Als | inhibits | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Type 2 Diabetes | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| genes-tlr2 | linked_to | wiki | 1.00 |
| C29 | inhibits | drug | 0.95 |
| Cyclosporine A | downregulates | drug | 0.92 |
| hypoxic-ischemic injury | upregulates | process | 0.88 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.82 |
| APOPTOSIS | associated_with | gene | 0.82 |
| LL37 | interacts_with | protein | 0.80 |
| APOPTOSIS | activates | gene | 0.80 |
| MICROGLIA | associated_with | cell_type | 0.74 |
| AMYLOID | associated_with | protein | 0.74 |
| NF-ΚB | activates | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| MTOR | associated_with | gene | 0.66 |
| IL-1B | associated_with | gene | 0.66 |
| HSP60 | causes | gene | 0.60 |
| HMGB1 | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| GSDMD | activates | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
| TLR | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
| RAGE | regulates | gene | 0.60 |
| CBL | inhibits | gene | 0.60 |
| MAPK1 | expressed_in | gene | 0.60 |
| S100A9 | expressed_in | gene | 0.60 |
| C3 | expressed_in | gene | 0.60 |
| JUN | interacts_with | gene | 0.60 |
| IL1B | regulates | gene | 0.60 |
| CD14 | associated_with | gene | 0.60 |
| CMKLR1 | regulates | gene | 0.60 |
| BAX | inhibits | gene | 0.60 |
| PSME3 | associated_with | gene | 0.60 |
| IL-17 | associated_with | gene | 0.60 |
| AMYLOID | therapeutic_target | gene | 0.60 |
| MICROGLIA ACTIVATION | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| CYTOKINES | therapeutic_target | gene | 0.60 |
| CCL2 | associated_with | gene | 0.60 |
| CMPK2 | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| AIFM1 | expressed_in | gene | 0.60 |
| NLRP3 | expressed_in | gene | 0.60 |
| TREM2 | expressed_in | gene | 0.60 |
| LRP1 | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alany | 0.550 | neurodegeneration | How does gut microbiome dysbiosis contri |
| Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu | 0.540 | neurodegeneration | How does gut microbiome dysbiosis contri |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning TLR2 in their description or question text
No additional research found